Authors
Latest:
Key Considerations in Treatment of Spinal Muscular Atrophy / Considerações essenciais para o tratamento da atrofia muscular espinhalThe expert panel shares clinical pearls for treatment and management of Spinal Muscular Atrophy. O painel de especialistas compartilha recomendações valiosas para o tratamento e manejo da atrofia muscular espinhal.
Latest:
Stanford Children’s Health: A Comprehensive Approach to Care for a Child With a Neurological ConditionPhysicians from Stanford Children’s Health offer their keys to successful pediatric neuroscience teams and what to focus on to provide a better quality of life for children.
Latest:
Uncovering New, Synergistic Ways to Treat Tuberous Sclerosis Complex: Darcy Krueger, MD, PhDThe director of the Tuberous Sclerosis Clinic at Cincinnati Children’s provided insight on whether the timing and combination of certain therapeutics may impact the long-term care for patients with tuberous sclerosis complex. [WATCH TIME: 3 minutes]
Latest:
Understanding the Association Between Obstructive Sleep Apnea Treatment and Dementia Risk: Galit L. Dunietz, PhD, MPHThe assistant professor of neurology at the University of Michigan provided context on a previous study which suggested that treatment of obstructive sleep apnea may reduce the risk of subsequent dementia. [WATCH TIME: 3 minutes]
Latest:
Expanding the Understanding of ALS With New Methods: Brian Wainger, MD, PhDThe assistant professor of neurology and anesthesiology at Harvard Medical School discussed non-traditional ways ALS research is changing and where the focus should continue to be.
Latest:
Targeting Inflammation to Reduce Effects of Alzheimer Disease: RJ Tesi, MDThe president and chief executive officer of INmune Bio detailed the mechanistic advantages of XPro1595 as a potentially therapeutic benefit for patients with Alzheimer disease and dementia. [WATCH TIME: 5 minutes]
Latest:
Improving Recognition, Diagnosis of Psychogenic Nonepileptic Seizures: Becky Tilahun, PhDThe clinical psychologist at Cleveland Clinic provided insight on the tricky nature of diagnosing a patient with nonepileptic seizures and the difficult conversations that can ensue. [WATCH TIME: 3 minutes]
Latest:
The Quick Neurologic Examination Tool in the PICU: Apirada Thongsing, MDThe resident physician at Montefiore Medical Center shared her experience with the novel and standardized quick examination tool and the data presented at AAN 2022. [WATCH TIME: 3 minutes]
Latest:
Quality of Life Improvements in MS Following Wellness Program: Brian Hutchinson, PT, MSCSThe director of the Multiple Sclerosis Achievement Center in Sacramento discussed 3-year data from an assessment of the program, outlining key findings and future research efforts. [WATCH TIME: 6 minutes]
Latest:
Migraine Management During Pregnancy, Women’s Healthcare Providers vs. Headache Specialists: Stephanie Bakaysa, MDThe maternal fetal medicine specialist at Hartford HealthCare Medical Group talked about the challenges of prescribing migraine treatment during pregnancy. [WATCH TIME: 4 minutes]
Latest:
WVE-004 Treatment for C9orf72 ALS and FTD: Merit Cudkowicz, MDThe director of the Sean M. Healey & AMG Center for ALS outlined the trial, which will evaluate ideal dose level and frequency of the investigational treatment for patients with C9-ALS and C9-FTD.
Latest:
Parkinson’s Disease: Advice for Community NeurologistsExpert neurologists provide insight on how to decide on an on-demand therapy for Parkinson’s disease and provide some general advice.
Latest:
Challenges of Targeting Cytokines in MS: Stephanie Blandford, MScThe PhD candidate at the neuroimmunology laboratory at Memorial University of Newfoundland discussed the potential of interleukin-1 receptor antagonist as a biomarker in MS disability as well as a therapeutic target.
Latest:
Addressing Unmet Needs in Narcolepsy Management: Practical Insight for Community-Based PhysiciansClosing out his discussion on narcolepsy management, Chris Winter, MD, highlights current unmet needs and shares practical advice for community physicians.
Latest:
James Grotta, MD: The Future of Stroke Care Going into 2021The vascular neurologist at Memorial Hermann Medical Group explained how clinical stroke care will change in 2021 amid the COVID-19 pandemic.
Latest:
Positive Signs From Prasinezumab in Parkinson Disease: Gennero Pagano, MD, MSc, PhDThe expert medical director at Roche provided detail on results from the phase 2 PASADENA study presented at the 2021 MDS Virtual Congress. [WATCH TIME: 3 minutes]
Latest:
The Ever-Expanding Multiple Sclerosis TherapeuticsJoin Ahmed Obeidat, MD, PhD; Mitchell Freedman, MD; and Suma Shah, MD, for the second program of this monthly series as they discuss the evolution of therapeutics for the treatment of multiple sclerosis.
Latest:
AUPN Leadership Minute Episode 26: Creating a Formal Junior Faculty Development PlanEpisode 9 of the AUPN Leadership Minute features Tracey A. Milligan, MD, of New York Medical College; and Larry B. Goldstein, MD, of University of Kentucky Medical Center. [WATCH TIME: 8 minutes]
Latest:
Approaching Treatment for MS ManagementDrs Ahmed Zayed Obeidat and Mark S. Freedman share considerations for individualized therapy for the management of MS.
Latest:
Integrating Machine Learning, Digital Platforms to Alzheimer Trials: David Bates, PhDThe chief executive officer and co-founder of Linus Health discussed screening tools for early cognitive decline and overcoming the complexities with using new-age technology. [WATCH TIME: 3 minutes]
Latest:
Future of Relapsing MS ManagementKey opinion leaders in multiple sclerosis (MS) discuss the future of relapsing MS management and unmet needs.
Latest:
Future Aspirations of Neonatal Seizure Research: Solomon Moshe, MD; Elissa Yozawitz, MDThe duo from Montefiore Medical Center discussed aspects of their recently published recommendations on neonatal seizure diagnosis that need further examining.
Latest:
Navigating an Expanding Treatment Toolbox for MS“Is more always better?”: The age-old question is more relevant than ever as clinicians and patients alike navigate an increasingly crowded MS treatment landscape.
Latest:
Optimizing the Migraine ConsultationProper diagnosis and effective treatment planning can drastically improve quality of life for individuals with migraine.
Latest:
Future of Treating Alzheimer DiseaseDrs Richard S. Isaacson and Marc E. Agronin look to the future of treating Alzheimer disease with the emphasis on early diagnosis.
Latest:
Assessing Efficacy of Fibroblast Cell Technology in MS and Directing Future Clinical Study: Hamid Khoja, PhDDiscussing data from an early safety study, the chief scientific officer of FibroBiologics commented on the benefits of a staggered approach to their clinical research in multiple sclerosis. [WATCH TIME: 5 minutes]
Latest:
AUPN Leadership Minute Episode 10: What Your CEO Wants From YouEpisode 10 of the AUPN Leadership Minute features Mud M Alvi, MD, of West Virginia University and Robert C. Byrd Health; and Albert L. Wright, Jr., the president and CEO of West Virginia University Health System. [WATCH TIME: 4 minutes]
Latest:
Next Steps in Understanding Cognitive Decline in Aging MS: Dejan Jakimovski, MD, PhDThe research assistant professor at the Buffalo Neuroimaging Analysis Center provided context on how different forms of multiple sclerosis impact cognitive decline in patients. [WATCH TIME: 4 minutes]
